Clinical trials: Febrile Neutropenia
Vancomycin, Hematologic Malignancies
Optimal Dosing of Vancomycin in an Adult Population of Hemato-oncology
This is a single-center prospective pharmacokinetic study. The principal objective is to collect new data among patients with hematologic cancer to develop a Bayesian population pharmacokinetic model and to improve dose…
- Conditions
- Vancomycin, Hematologic Malignancies, Febrile Neutropenia
- Trial name
- Hemato-Vanco (NCT04758442)
- Testing
- Additional blood sample
- Where
- Canada
- Volunteers
- 40 people
- Sponsor
- Ciusss de L'Est de l'Île de Montréal
Febrile Neutropenia
Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection
This study will treat patients who have fever and neutropenia (after cancer chemotherapy) that is possibly due to a specific bacteria (gram positive bacteria).
- Trial name
- NCT00035425
- Testing
- linezolid, vancomycin
- Where
- 40 sites in United States, Argentina and 8 more
- Volunteers
- 120 people
- Sponsor
- Pfizer
Cancer
Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment
RATIONALE: Caspofungin acetate or amphotericin B liposomal may be effective in preventing or controlling fever and neutropenia caused by chemotherapy, bone marrow transplantation, or peripheral stem cell transplantation.
- Trial name
- NCT00008359
- Testing
- caspofungin acetate, liposomal amphotericin B
- Where
- United States
- Sponsor
- Memorial Sloan Kettering Cancer Center